INDP Indaptus Therapeutics Inc

P/E --
Forward P/E --
Price/Sales --
Beta 1.181
Div Yield --
Market Cap --

Company Analysis

Latest News

🟒 Indaptus Therapeutics is trading 5.81% up in pre-market with no clear catalyst identified

Indaptus Therapeutics is trading 5.81% up at $1.25 after no clear company-specific catalyst was identified for August 10, 2026. - Its virtual annual meeting...

πŸ”΄ Indaptus Therapeutics is trading 10.24% down today β€” no clear company-specific catalyst

Indaptus Therapeutics is trading 10.24% down now at $1.19 after searches found no clear company-specific announcement explaining the August 6, 2026 decline. -...

πŸ”΄ Indaptus Therapeutics is trading 9.78% down today β€” no clear company-specific catalyst

Indaptus Therapeutics is trading 9.78% down now at $1.20 after no clear company-specific catalyst emerged in the August 6, 2026 news search. - Recent coverage...

🟒 Indaptus Therapeutics is trading 14.29% up today on speculative trading with no clear catalyst

Indaptus Therapeutics is trading at $1.52 (+14.29%) in pre-market sessions despite a lack of identifiable company-specific catalysts in current news flow. *...

🟒 Indaptus Therapeutics is trading 5.3% up today on technical buying and risk-on sentiment

Indaptus Therapeutics is trading 5.3% up at $1.38 as the stock stages a technical rebound following a sharp multi-day selloff. β€’ The recovery follows a period...

πŸ”΄ Indaptus Therapeutics is trading 7.6% down today reversing an earlier technical rebound

Indaptus Therapeutics is trading at $1.21 (7.6% down) in after-hours trading, reversing part of a sharp intraday rebound. β€’ The stock climbed approximately...

🟒 Indaptus Therapeutics is trading 10.1% up today on a technical rebound after a sharp multi-day selloff

Indaptus Therapeutics is trading 10.1% up at $1.42 in what appears to be a technical rebound after a sharp multi-day selloff. β€’ There are no fresh...

🟒 Indaptus Therapeutics is trading 5% up today on a technical rebound after recent declines

Indaptus Therapeutics is trading 5% higher at $1.36 in a technical rebound following several days of sharp declines and profit-taking. β€’ The move comes...

πŸ”΄ Indaptus Therapeutics is trading 10.4% down today after continued post-rally profit-taking

Indaptus Therapeutics is trading at $1.29 (-10.42%) as the stock faces a second day of sharp selling driven by post-rally profit-taking following a steep...

πŸ”΄ Indaptus Therapeutics is trading 5.6% down today on continued post-rally profit-taking

Indaptus Therapeutics is trading 5.6% down at $1.36 as traders continue to lock in gains following the stock's recent sharp rebound. β€’ The decline follows a...

πŸ”΄ Indaptus Therapeutics is trading 13.5% down today on profit-taking after a multi-day rebound

Indaptus Therapeutics is trading 13.5% down at $1.57 as investors engage in profit-taking and short-term selling following a sharp multi-day rally. β€’ The...

πŸ”΄ Indaptus Therapeutics is trading 5.8% down today on profit-taking after recent rebound

Indaptus Therapeutics is trading 5.8% down at $1.72 on profit-taking following a sharp multi-day rebound. β€’ The stock's decline follows a period of...

🟒 Indaptus Therapeutics is trading 6.6% up today on broader market rebound

Indaptus Therapeutics is trading at $1.94 (+6.6%) in pre-market sessions, recovering from yesterday’s risk-off driven after-hours decline. β€’ The upward move...

πŸ”΄ Indaptus Therapeutics is trading 7.1% down today amid thin after-hours liquidity and a broader risk-off backdrop

Indaptus Therapeutics is trading at $1.69 (-7.14%) in after-hours trading after closing the regular session at $1.82, with the move appearing to be driven by...

🟒 Indaptus Therapeutics is trading 5.2% up today as it rebounds from a steep two-day selloff

Indaptus Therapeutics is trading at $1.82 (+5.20%) as the stock stages a volatile rebound following a steep two-day selloff. β€’ The move appears to be a...

INDP Drops 33% From Last Week's Peak β€” Is the Pullback a Reset or a Red Flag for This Micro-Cap Biotech?

INDP Drops 33% From Last Week's Peak β€” Is the Pullback a Reset or a Red Flag for This Micro-Cap Biotech?

Shares of Indaptus Therapeutics tumbled another 14% to $1.75 on Tuesday, extending a punishing slide that has now erased roughly a third of the stock's value...

πŸ”΄ Indaptus Therapeutics is trading 11% down today as profit-taking extends multi-day slide

Indaptus Therapeutics is trading 11% down today at $1.75 as investors continue to lock in profits following a recent sharp rally. β€’ The move extends a period...

πŸ”΄ Indaptus Therapeutics is trading 17.2% down today as Friday's selloff extends amid profit-taking

Indaptus Therapeutics is trading at $2.09 (17.2% down) today as early pre-market strength faded and Friday’s selloff extended into the new week. β€’ The decline...

πŸ”΄ Indaptus Therapeutics is trading 7.3% down today as pre-market gains reverse

Indaptus Therapeutics is trading at $2.42 (-7.28%) as the stock reverses its earlier pre-market rebound. β€’ The decline follows a selloff on Friday, with the...

🟒 Indaptus Therapeutics is trading 10% up today as it rebounds from Friday's pullback

Indaptus Therapeutics is trading at $2.87 (+10%) in pre-market, staging a recovery after shares fell approximately 5–7% during Friday's profit-taking...